( NASDAQ-SMALL:CRME, Toronto:COM )

News from Cardiome Pharma Corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 17, 2017, 08:00 ET Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen

NASDAQ: CRME TSX: COM VANCOUVER, July 17, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that the Therapeutic...


Jul 03, 2017, 08:00 ET Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension

NASDAQ:CRME TSX:COM VANCOUVER, July 3, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that partner SteadyMed...


Jun 23, 2017, 08:00 ET Cardiome Pharma Corp. Announces Voting Results

NASDAQ:CRME TSX:COM VANCOUVER, June 23, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the results of...


Jun 21, 2017, 08:00 ET Cardiome Announces Licensing Agreement for XYDALBA™ (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel

NASDAQ:CRME TSX:COM VANCOUVER, June 21, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that its affiliate...


Jun 12, 2017, 07:30 ET Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada

NASDAQ:CRME TSX:COM VANCOUVER, June 12, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that it received...


May 16, 2017, 08:00 ET Cardiome Reports Changes To Senior Management Team

NASDAQ: CRME TSX: COM VANCOUVER, May 16, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced a number of changes...


May 15, 2017, 16:00 ET Cardiome Reports First Quarter 2017 Financial Results

NASDAQ: CRME TSX: COM Cardiome to conduct conference call and webcast today, May 15, 2017 at 4:30 p.m. Eastern (1:30 p.m. Pacific) VANCOUVER,...


May 15, 2017, 08:00 ET Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

NASDAQ: CRME TSX: COM VANCOUVER, May 15, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today...


May 08, 2017, 08:00 ET Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15

NASDAQ: CRME TSX: COM VANCOUVER, May 8, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report...


Apr 27, 2017, 08:00 ET Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference

NASDAQ: CRME TSX: COM VANCOUVER, April 27, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that David Dean, VP...


Apr 06, 2017, 08:00 ET Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study

NASDAQ: CRME TSX: COM VANCOUVER, April 6, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) updated today that its partner,...


Apr 03, 2017, 08:00 ET Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review

NASDAQ: CRME TSX: COM VANCOUVER, April 3, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) updated today that its partner,...


Mar 14, 2017, 15:02 ET Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS

NASDAQ: CRME TSX: COM VANCOUVER, March 14, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced today that it received a...


Mar 07, 2017, 16:00 ET Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results

NASDAQ: CRME TSX: COM Cardiome to conduct conference call and webcast today, March 7, 2017 at 4:30 p.m. Eastern (1:30 p.m. Pacific) VANCOUVER,...


Mar 03, 2017, 08:00 ET Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in France

NASDAQ: CRME TSX: COM VANCOUVER, March 3, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced today that it received...


Feb 27, 2017, 08:00 ET Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7

NASDAQ: CRME TSX: COM VANCOUVER, Feb. 27, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report...


Dec 20, 2016, 08:00 ET Cardiome Announces Commercial Launch of XYDALBA™ (dalbavancin) in Germany

NASDAQ: CRME TSX: COM VANCOUVER, Dec. 20, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has initiated the...


Dec 08, 2016, 11:55 ET Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in the UK

NASDAQ: CRME TSX: COM VANCOUVER, Dec. 8, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has launched...


Nov 29, 2016, 08:00 ET Cardiome Advances Toward the UK XYDALBA™ (dalbavancin) Launch

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 29, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) is pleased to announce that it has...


Nov 01, 2016, 08:00 ET Cardiome to Reschedule Release of Third Quarter 2016 Financial Results

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 1, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it is...


Oct 28, 2016, 08:00 ET Cardiome to Hold Third Quarter 2016 Financial Results Conference Call on November 7

NASDAQ: CRME TSX: COM VANCOUVER, Oct. 28, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will...


Oct 14, 2016, 08:00 ET Cardiome Announces Initiation of Commercial Operations in Canada, Eh

NASDAQ: CRME TSX: COM VANCOUVER, Oct. 14, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has initiated...


Aug 16, 2016, 08:00 ET Cardiome Announces Recent Insider Purchases

NASDAQ: CRME  TSX: COM VANCOUVER, Aug. 16, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announces that Dr....


Aug 09, 2016, 16:00 ET Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency

NASDAQ: CRME  TSX: COM VANCOUVER, Aug. 9, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that...


Aug 09, 2016, 16:00 ET Cardiome Reports Second Quarter 2016 Financial Results

Cardiome to conduct conference call and webcast today, August 9, 2016 at 4:30pm Eastern (1:30pm Pacific) NASDAQ: CRME     TSX:...